-+ 0.00%
-+ 0.00%
-+ 0.00%
GH Research Appoints Vanina Popova as Chief Development Officer
Share
Listen to the news
GH Research Appoints Vanina Popova as Chief Development Officer
  • GH Research appointed Vanina Popova as chief development officer.
  • Popova will lead GH001 clinical development into pivotal programs for treatment-resistant depression and postpartum depression.
  • She joins from Johnson & Johnson following more than 20 years in neuroscience, including leading the pivotal TRANSFORM-2 trial for Spravato.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GH Research plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130755PRIMZONEFULLFEED9877164) on November 13, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending